Institutional investors purchased a net $653.4 thousand shares of BGMD during the quarter ended December 2014, and now own 10.56% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELCH & FORBES LLC Sold 963.00 shares of BG Medicine Inc